FXYD5 and neoplasm: Interestingly, the extent of the increase in dysadherin expression in the tumor epithelium was significantly correlated with tumor T stage and recurrence (Table S4), and dysadherin expression was an independent and significant prognostic marker of poor clinical outcomes, short OS and RFS in patients with CRC (Figure 2E,F).